Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Privia Health Group Inc (NASDAQ: PRVA) closed at $23.07 down -1.07% from its previous closing price of $23.32. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
For a deeper understanding of Privia Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.88 and its Current Ratio is at 1.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’25 when Mehrotra Parth sold 15,909 shares for $24.52 per share. The transaction valued at 390,089 led to the insider holds 407,234 shares of the business.
Mehrotra Parth sold 13,773 shares of PRVA for $344,187 on May 12 ’25. The Chief Executive Officer now owns 423,143 shares after completing the transaction at $24.99 per share. On May 12 ’25, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 3,322 shares for $24.99 each. As a result, the insider received 83,017 and left with 172,909 shares of the company.
Valuation Measures:
As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 186.65, and their Forward P/E ratio for the next fiscal year is 69.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.56 while its Price-to-Book (P/B) ratio in mrq is 4.25.
Stock Price History:
Over the past 52 weeks, PRVA has reached a high of $26.09, while it has fallen to a 52-week low of $16.37. The 50-Day Moving Average of the stock is -1.49%, while the 200-Day Moving Average is calculated to be 7.45%.
Shares Statistics:
A total of 121.39M shares are outstanding, with a floating share count of 107.96M. Insiders hold about 11.45% of the company’s shares, while institutions hold 94.88% stake in the company.
